aTyr Pharma ATYR Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -105.3%+2.5pp | -107.8%-4.6pp | -103.2%-18.0pp | -85.2%-5.7pp | -79.5%+0.2pp | |
| Return on invested capital | -105.9%+3.3pp | -109.2%-7.7pp | -101.5%-13.9pp | -87.5%-8.9pp | -78.6%+8.0pp | |
| Liquidity | ||||||
| Current ratio | 5.8×+0.5× | 5.3×-0.6× | 5.9×+0.3× | 5.6×-2.2× | 7.8×+2.3× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Per Share | ||||||
| Book value per share | $0.59-18.6% | $0.73-12.1% | $0.83-0.6% | $0.83-4.3% | $0.87-8.0% | |
| Valuation | ||||||
| Market capitalization | $54.88M-88.2% | —— | —— | —— | —— | |
| Price / book | 0.9×— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do aTyr Pharma's ratios come from?
- Every ratio is computed from aTyr Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
